This Healthcare Tech Company Is Mulling Strategic Options, Analyst Gets Bullish On Stock
Portfolio Pulse from Vandana Singh
Cantor Fitzgerald has initiated coverage on NextGen Healthcare Inc (NASDAQ:NXGN) with a price target of $21 and an Overweight rating. The company is exploring strategic options, including a potential sale, and has hired Morgan Stanley as an advisor. NextGen's health data platform, MirthConnect, is integrated into a third of all US Health Information Exchanges and extended across 39 nations. The company is on track to meet its three-year plan to sell an extra $100 million in products to current clients.
August 28, 2023 | 6:37 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
NextGen Healthcare is exploring strategic options, including a potential sale, which could impact its stock price. Cantor Fitzgerald has initiated coverage with a $21 price target, indicating a bullish outlook. The company's progress towards its sales target also suggests potential growth.
The news of NextGen Healthcare exploring strategic options, including a potential sale, could lead to increased investor interest and potentially drive up the stock price. The bullish rating from Cantor Fitzgerald further supports this potential upward movement. Additionally, the company's progress towards its sales target indicates a positive outlook for its financial performance, which could also positively impact the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100